REDOXIS
Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions. They provide in vivo of RA, MS, GBS and SLE. In addition, they have a fully equipped lab with capacity to perform in vitro and ex vivo follow up assays and a wide range of immunology assays to provide you everything form MoA studies to PK and in vivo efficacy studies. Please visit www.redoxis.com for further information or contact us directly for quotes and discussion on model selection (free of charge).
REDOXIS
Social Links:
Industry:
Health Care
Founded:
2007-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.redoxis.se
Total Employee:
1+
Status:
Active
Contact:
+46707259565
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Apache Microsoft Exchange Online
Investors List
Eurostars
Eurostars investment in Grant - Redoxis
Newest Events participated
Participated in The Future of Swedish & Danish Life Science 2017
on 2017-03-30 as exhibitor
Participated in The Future of Swedish & Danish Life Science 2017
on 2017-03-30 as sponsor
Official Site Inspections
http://www.redoxis.se Semrush global rank: 9.72 M Semrush visits lastest month: 114
- Host name: web.dinstudio.net
- IP address: 159.253.26.222
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Redoxis"
Personal and efficient collaboration | Redoxis
Redoxis is a Swedish CRO with a core competence and experience in preclinical models for autoimmune and inflammatory conditions. We provide a wide range of in vivo and in vitro …See details»
Redoxis is a CRO with core expertise | Redoxis
Redoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of inflammatory and autoimmune diseases.See details»
Background of Redoxis | Redoxis
Redoxis was founded in Sweden in 2007 as a R&D spinout with focus on preclinical development of small molecules targeting molecular pathways in the immunological responses associated …See details»
Redoxis AB - MVA
Redoxis is a Swedish CRO with a core competence and experience in preclinical models for autoimmune and inflammatory conditions. We provide a wide range of in vivo and in vitro …See details»
Redoxis - swedenbio.se
Redoxis is a preclinical CRO with a core competence and experience in models for autoimmune and inflammatory diseases. They provide a wide range of in vivo and in vitro models for …See details»
Redoxis AB | LinkedIn
Redoxis is a preclinical boutique CRO specializing on inflammation and autoimmune conditions. We provide in vivo, ex vivo and in vitro preclinical efficacy and MoA studies.See details»
Redoxis - Crunchbase Company Profile & Funding
Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions. They provide in vivo of RA, MS, GBS and SLE. In addition, they have a fully equipped lab with capacity to perform in vitro and ex vivo follow up …See details»
Redoxis
Join us in our quest to become the best service provider in the area of preclinical inflammation through our competence, our dedication, our flexibility and our personal relationship with …See details»
Management | Redoxis
Redoxis is a privately held company owned by founders, personnel and the investment firm Sätila MedTech AB. Professor Rikard Holmdahl (PhD, MD) has been a professor of medical …See details»
Redoxis Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Redoxis. Use the PitchBook Platform to explore the full profile.See details»
Redoxis AB Company Profile | Lund, Skåne, Sweden | Competitors ...
Find company research, competitor information, contact details & financial data for Redoxis AB of Lund, SkÃ¥ne. Get the latest business insights from Dun & Bradstreet.See details»
Redoxis - Medicon Village
Redoxis erbjuder tjänster inom preklinisk läkemedelsutveckling med fokus pÃ¥ inflammation och autoimmunitet. Vi erbjuder skräddarsydda studier individuellt anpassade för varje kund. …See details»
Redoxis grand lab opening celebration - Medicon Village
Nov 17, 2024 · It provides opportunities for existing companies like Alligator Bioscience, Cellevate, Redoxis, SARomics Biostructures, and Truly to expand while also allowing new …See details»
Meet our team - Redoxis
Polyxeni joined Redoxis in 2023 and with her extensive experience in immunology, she will strengthen the immunological profile of the company and further develop Redoxis’ immune …See details»
Redoxis - Products, Competitors, Financials, Employees, …
Redoxis is a Contract Research Organization (CRO) with a focus on preclinical drug development and efficacy evaluation in the field of autoimmune diseases. Use the CB Insights Platform to …See details»
Redoxis AB - 556726-4451 - Lund - Se Nyckeltal, Befattningar med …
Allabolag.se ger dig företagsinformation om Redoxis AB, 556726-4451. Hitta adress pÃ¥ karta, kontaktinfo, nyckeltal och befattningar.See details»
Redoxis Company Profile - Office Locations, Competitors ... - Craft
Redoxis is a company that delivers customized services in preclinical inflammation. It provides in vivo and in vitro models with a focus on autoimmunity and inflammatory conditions. The …See details»
Latest news updates | News - redoxis.se
Jan 27, 2023 · Redoxis signs license agreement with VivoLogica. Redoxis AB recently signed a license agreement with VivoLogica for use of their software platform for in vivo study …See details»
pronoxis.com
ProNoxis AB was founded in 2009 by LU Bioscience AB (LUBio), Karolinska Development AB, and Redoxis AB, as a Redoxis spin-off focusing on developing anti-inflammatory therapeutics …See details»
Partners and Subsidiaries - Redoxis
In order to strengthen our service capabilities further, we have established collaborations with validated partners for technologies adding additional value to our established services as well …See details»